Cargando…

Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer’s disease

BACKGROUND: Several blood-based biomarkers are promising to be used in the diagnosis of Alzheimer’s disease (AD) including Aβ42/40, p-tau181, and neurofilament light (NfL). The kidney is associated with the clearance of proteins. It is crucial to evaluate the effect of renal function on the diagnost...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Bin, Zhang, Cheng, Wang, YuYe, Chen, LeiAn, Qiao, YaNan, Wang, Yu, Peng, DanTao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050758/ https://www.ncbi.nlm.nih.gov/pubmed/37009461 http://dx.doi.org/10.3389/fnagi.2023.1150510

Ejemplares similares

Plasma tau proteins for the diagnosis of mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis
por: Chen, Leian, et al.
Publicado: (2022)

The preservation of right cingulum fibers in subjective cognitive decline of preclinical phase of Alzheimer’s disease
por: Sun, Yu, et al.
Publicado: (2023)

Altered local and remote functional connectivity in mild Alzheimer’s disease patients with sleep disturbances
por: Wang, Lei, et al.
Publicado: (2023)

Genetic Insights into Obesity and Brain: Combine Mendelian Randomization Study and Gene Expression Analysis
por: Chen, Leian, et al.
Publicado: (2023)

Identification of novel diagnostic panel for mild cognitive impairment and Alzheimer’s disease: findings based on urine proteomics and machine learning
por: Wang, Yuye, et al.
Publicado: (2023)

Mechanism of ERK/CREB pathway in pain and analgesia
por: Zhen, Weizhe, et al.
Publicado: (2023)

Identification of TLR2 as a Key Target in Neuroinflammation in Vascular Dementia
por: Wang, Yuye, et al.
Publicado: (2022)

Integrated bioinformatics-based identification of diagnostic markers in Alzheimer disease
por: Chen, Danmei, et al.
Publicado: (2022)

Exploration of novel biomarkers in Alzheimer’s disease based on four diagnostic models
por: Zou, Cuihua, et al.
Publicado: (2023)

X chromosome-wide association study of quantitative biomarkers from the Alzheimer’s Disease Neuroimaging Initiative study
por: Wang, Kai-Wen, et al.
Publicado: (2023)

Identification of potential M2 macrophage-associated diagnostic biomarkers in coronary artery disease
por: Li, Kunlin, et al.
Publicado: (2022)

Associations of multiple visual rating scales based on structural magnetic resonance imaging with disease severity and cerebrospinal fluid biomarkers in patients with Alzheimer’s disease
por: Wan, Mei-dan, et al.
Publicado: (2022)

Research on digital tool in cognitive assessment: a bibliometric analysis
por: Chen, Leian, et al.
Publicado: (2023)

Editorial: Neuroimaging Biomarkers and Cognition in Alzheimer's Disease Spectrum
por: Chen, Jiu, et al.
Publicado: (2022)

Associations between blood-based biomarkers of Alzheimer’s disease with cognition in motoric cognitive risk syndrome: A pilot study using plasma Aβ42 and total tau
por: Chen, Pei-Hao, et al.
Publicado: (2022)

Association between cerebrospinal fluid clusterin and biomarkers of Alzheimer’s disease pathology in mild cognitive impairment: a longitudinal cohort study
por: Wang, Hao, et al.
Publicado: (2023)

Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer’s disease
por: Yu, Weiwei, et al.
Publicado: (2021)

The Influence of 24-h Ambulatory Blood Pressure on Cognitive Function and Neuropathological Biomarker in Patients With Alzheimer's Disease
por: Li, Lixia, et al.
Publicado: (2022)

Corrigendum: Associations between blood-based biomarkers of Alzheimer's disease with cognition in motoric cognitive risk syndrome: A pilot study using plasma Aβ42 and total tau
por: Chen, Pei-Hao, et al.
Publicado: (2023)

Alzheimer’s disease: an axonal injury disease?
por: Dan, Liang, et al.
Publicado: (2023)

Plasma-derived phosphoglycerate mutase 5 as a biomarker for Parkinson’s disease
por: Feng, Liang, et al.
Publicado: (2022)

Editorial: Additive or synergistic impacts of sleep, circadian rhythm disturbances and other modifiable risk factors on established and novel plasma biomarkers of Alzheimer's disease pathology
por: Bubu, Omonigho M., et al.
Publicado: (2023)

Impact prediction of translocation of the mitochondrial outer membrane 70 as biomarker in Alzheimer's disease
por: Cao, Xi, et al.
Publicado: (2022)

Effects of DISC1 on Alzheimer’s disease cell models assessed by iTRAQ proteomics analysis
por: Lu, Jiajie, et al.
Publicado: (2022)

Hub Genes, Diagnostic Model, and Predicted Drugs Related to Iron Metabolism in Alzheimer's Disease
por: Gu, Xuefeng, et al.
Publicado: (2022)

Exploring the common pathogenesis of Alzheimer’s disease and type 2 diabetes mellitus via microarray data analysis
por: Ye, Xian-wen, et al.
Publicado: (2023)

Loop diuretics association with Alzheimer’s disease risk
por: Graber-Naidich, Anna, et al.
Publicado: (2023)

Altered functional association and couplings: Effective diagnostic neuromarkers for Alzheimer’s disease
por: Zhao, Chongyi, et al.
Publicado: (2022)

Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset
por: Homann, Jan, et al.
Publicado: (2022)

G-quadruplexes and associated proteins in aging and Alzheimer’s disease
por: Vijay Kumar, M. J., et al.
Publicado: (2023)

Editorial: Translational advances in Alzheimer's, Parkinson's, and other dementia: Molecular mechanisms, biomarkers, diagnosis, and therapies, volume II
por: Jiang, Jiehui, et al.
Publicado: (2022)

Emerging Electroencephalographic Biomarkers to Improve Preclinical to Clinical Translation in Alzheimer’s Disease
por: Cope, Zackary A., et al.
Publicado: (2022)

Associations of Polygenic Risk Score for Late-Onset Alzheimer's Disease With Biomarkers
por: Li, Qiaojun, et al.
Publicado: (2022)

Effects of copy number variations on longevity in late-onset Alzheimer’s disease patients: insights from a causality network analysis
por: Hao, Yanan, et al.
Publicado: (2023)

Prediction Models for Conversion From Mild Cognitive Impairment to Alzheimer’s Disease: A Systematic Review and Meta-Analysis
por: Chen, Yanru, et al.
Publicado: (2022)

Simufilam suppresses overactive mTOR and restores its sensitivity to insulin in Alzheimer’s disease patient lymphocytes
por: Wang, Hoau-Yan, et al.
Publicado: (2023)

Unraveling the connection between gut microbiota and Alzheimer’s disease: a two-sample Mendelian randomization analysis
por: Zeng, Huiqiong, et al.
Publicado: (2023)

Association between gray matter atrophy, cerebral hypoperfusion, and cognitive impairment in Alzheimer’s disease
por: Dong, Haoyang, et al.
Publicado: (2023)

Editorial: Molecular mechanisms of Alzheimer’s disease: From top to bottom
por: Mello-Carpes, Pâmela B., et al.
Publicado: (2022)

Neuropathology of Aging in Cats and its Similarities to Human Alzheimer’s Disease
por: Sordo, Lorena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kr9jh1224j7kkchu68fh6a39rn